※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
09:00-10:15
- Panel Discussion 1:
- How to Manage Old-aged Breast Cancer Patients?
- Venue: RM 2(Vista 3)
- Education Session 1:
- Radiologist’s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer
- Venue: RM 3(Walker Hall 1)
- Causes of Over- and Underestimation of Tumor and Axillary LN After Neoadjuvant System Therapy
- Beatriu Reig
- (NYU Langone Health, U.S.A.)
Slide ViewVideo ViewAbstract
- Evaluation of Response to Neoadjuvant Systemic Therapy: Multiparametric Approach for Accurate Evaluation of Residual Tumor
- Masako Kataoka
- (Kyoto Univ., Japan)
Slide ViewVideo ViewAbstract
- How to Manage Residual Microcalcifications After Neoadjuvant Chemotherapy
- Sung Hun Kim
- (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Slide ViewVideo ViewAbstract
- Symposium 1:
- Recent Strategies for ER+/HER2- Breast Cancer
- Venue: RM 1(Vista 1+2)
- Optimal Duration of Endocrine Therapy
- Polly Suk Yee Cheung
- (Hong Kong Sanatorium and Hospital, Hong Kong)
Slide ViewVideo ViewAbstract
- The Role of CDK4/6 Inhibitors in ER+/HER2- Early Breast Cancer
- Tadahiko Shien
- (Okayama Univ. Hospital, Japan)
Slide ViewVideo ViewAbstract
- ER+/HER2 Negative Premenopausal Breast Cancer- The Biomarker Way Forward
- Peter C. Dubsky
- (Hirslanden Klinik St. Anna, Switzerland)
Slide ViewVideo ViewAbstract
- Oral Presentation 1
-
- Venue: RM 4(Walker Hall 2)
- GBCC-SSO Joint Session:
- Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists
- Venue: RM 5(Art Hall)
- Management of Hereditary Breast Cancer in the U.S.
- Tolga Ozmen
- (Massachusetts General Hospital, U.S.A.)
Abstract
- Management of Hereditary Breast Cancer in Europe
- Isabel T. Rubio
- (Clinica Universidad de Navarra, Spain)
Slide ViewVideo ViewAbstract
- Management of Hereditary Breast Cancer in Asia
- Sung-Won Kim
- (Daerim St. Mary's Hospital, Korea)
Slide ViewVideo ViewAbstract
10:30-11:45
- Education Session 2:
- Genomic Assays and Treatment Decision
- Venue: RM 3(Walker Hall 1)
- Optimal Decisions on Adjuvant Endocrine and Chemotherapy Using Multigene Assays
- Chi-Cheng Huang
- (Taipei Veterans General Hospital, Taiwan)
Slide ViewVideo ViewAbstract
- Clinical Parameters as Alternatives to Genomic Assays
- Jong Won Lee
- (ASAN Medical Center, Korea)
Slide ViewVideo ViewAbstract
- Interpretation of Genomic Assays in Premenopausal Women
- Kevin Kalinsky
- (Winship Cancer Institute of Emory Univ., U.S.A.)
Slide ViewVideo ViewAbstract
- Panel Discussion 2:
- Various Considerations in Premenopausal Breast Cancer Patients
- Venue: RM 2(Vista 3)
- The Optimal Endocrine Combination with OFS
- Hee Jeong Kim
- (ASAN Medical Center, Korea)
Slide ViewVideo ViewAbstract
- Targeted Therapy for High-risk Patients and gBRCA Mutation Patients
- Hee Kyung Ahn
- (Gachon Univ. Gil Medical Center, Korea)
Slide ViewVideo View
- Prophylactic Mastectomy
- Eric Schneider
- (Yale School of Medicine, U.S.A.)
- Symposium 2:
- HER2-Low as a Targetable Subset of Breast Cancer
- Venue: RM 1(Vista 1+2)
- Is HER2-Low Breast Cancer an Independent/Distinctive Subtype?
- Naoto Ueno
- (Univ. of Hawai'i Cancer Center, U.S.A.)
Slide ViewVideo ViewAbstract
- How to Identify HER2-Low Breast Cancer
- Hee Jin Lee
- (ASAN Medical Center, Korea)
Abstract
- Targeting HER2-Low and the Treatment Sequence
- Wei-Pang Chung
- (National Cheng Kung Univ. Hospital, Taiwan)
Slide ViewVideo ViewAbstract
- Oral Presentation 2
-
- Venue: RM 4(Walker Hall 2)
- GBCC-JBCS Joint Session:
- Holistic Management for Breast Cancer Patients in Pandemic Era
- Venue: RM 5(Art Hall)
12:00-12:45
- Plenary Lecture 1
-
- Venue: RM 1(Vista 1+2)
- A Revolution in the Making: How Antibody-Drug Conjugates are Transforming Breast Cancer Treatment
- Ian Krop
- (Yale School of Medicine, U.S.A.)
Slide ViewVideo ViewAbstract
13:00-13:45
- Satellite Symposium 1:
- MSD Korea
- Venue: RM 1(Vista 1+2)
14:00-14:45
- Plenary Lecture 2
-
- Venue: RM 1(Vista 1+2)
15:00-16:15
- Panel Discussion 3:
- Optimal Surgical Treatment After Neoadjuvant Chemotherapy
- Venue: RM 2(Vista 3)
- Avoiding Breast Surgery in Patients with Radiologic Complete Response
- Christoph Tausch
- (Breast-Center Zurich, Switzerland)
Slide ViewVideo ViewAbstract
- De-escalation of Sentinel Lymph Node Biopsy in Patients with Radiologic Complete Response
- Shih-Che Shen
- (Chang Gung Memorial Hospital, Taiwan)
Abstract
- De-escalation of Radiotherapy in Patients Achieved Pathologically Complete Response
- Yeon-Joo Kim
- (National Cancer Center, Korea)
Slide ViewVideo ViewAbstract
- Oral Presentation 3
-
- Venue: RM 4(Walker Hall 2)
- Symposium 3:
- Beyond CDK4/6 Inhibitor: New Target and New Drugs
- Venue: RM 3(Walker Hall 1)
- Novel Oral SERD and its Implication in Clinical Practice
- Yen-Shen Lu
- (National Taiwan Univ. Hospital, Taiwan)
Slide ViewVideo ViewAbstract
- Treatment Strategy After Progression on CDK4/6 Inhibitor
- Nadia Harbeck
- (LMU Univ. Hospital, Germany)
Abstract
- New Targets Beyond CDK4/6 Inhibitor: Development in Progress
- Yong Wha Moon
- (CHA Bundang Medical Center, Korea)
Abstract
- GBCC-TBCS Joint Session:
- Making Evidences Together
- Venue: RM 5(Art Hall)
16:30-17:45
- Education Session 3:
- Special Issues in Young Women with Breast Cancer Treated with Radiotherapy
- Venue: RM 2(Vista 3)
- Symposium 4:
- Tailored Surgery in Early-stage Breast Cancer
- Venue: RM 3(Walker Hall 1)
- Individualized Surgical Extent and Lumpectomy Margin in Early-stage Breast Cancer: Does Tumor Histology and Subtype Matter?
- Naoki Hayashi
- (Showa Univ. School of Medicine, Japan)
Abstract
- The Role of Axillary Surgery for DCIS and Early-stage Breast Cancer
- Wonshik Han
- (Seoul National Univ. Hospital, Korea)
Slide ViewVideo ViewAbstract
- Pre-operative Genomic Assay for Breast Surgery Guidance in HR+/HER2- Breast Cancer
- Caroline Drukker
- (Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Netherlands)
Slide ViewVideo ViewAbstract
- Oral Presentation 4
-
- Venue: RM 4(Walker Hall 2)
- GBCC-CACA Joint Session:
- Programs for Breast Cancer Screening and Prevention
- Venue: RM 5(Art Hall)
- KBCS Guidelines of Screening and Current Status
- Young-Joon Kang
- (The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
Slide ViewVideo ViewAbstract
- CACA Guidelines of Screening and Current Status
- Yongsheng Wang
- (Shandong Cancer Hospital & Institute, China)
Slide ViewVideo View
- Korean Recommendations for Prevention and Risk Managements
- Yoo Seok Kim
- (Chosun Univ. Hospital, Korea)
Slide ViewVideo View
- Chinese Recommendations for Prevention and Risk Managements
- Junjie Li
- (Fudan Univ. Shanghai Cancer Center, China)
6Fl., squareME Bldg., 225 Bongeunsa-ro, Gangnam-gu, Seoul 06109, Korea 
+82-2-3452-7291 
+82-2-565-2434
gbcc@intercom.co.kr
www.gbcc.kr
